Acute Kidney Injury (AKI) Therapeutics Segmental Analysis by Therapeutics, Diagnostics, Patient, Drugs Policy and Regulatory Landscape

According to a new research report “Acute Kidney Injury (AKI) Therapeutics - Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments” published by Pharma Proff, AKI therapeutics currently exhibits a proliferating pipeline...

Read More

Achondroplasia Therapeutics Pipeline Analysis -Drug Profile, Top Industry Intelligence and Therapeutic Development

Achondroplasia therapeutics currently exhibits a considerably strong pipeline with seven active drug candidates. Achondroplasia is a common disorder of dwarfism with disproportionate stature. It is an autosomal dominant disorder that occurs due to mutation in fibroblast...

Read More

Tardive Dyskinesia Therapeutics - Pipeline Analysis , Clinical Trials & Results, Patents, Designations, Collaborations

Tardive dyskinesia (TD) is an involuntary neurological movement disorder caused by the use of dopamine receptor blocking drugs which are prescribed to treat certain psychiatric or gastrointestinal conditions. Long-term use of these drugs may produce biochemical abnormalities...

Read More

Major Depressive Disorder Therapeutics - Pipeline Analysis , Clinical Trials & Results, Patents

Major depressive disorder, also known as the clinical depression, is characterized by a constant sense of despair and hopelessness. It usually affects daily activities such as study, sleep, and eating. Access Detailed Report Summary: https://www.pharmaproff.com/report/major-depressive-disorder-therapeutics-pipeline-analysis Common symptoms...

Read More

Lewy Body Dementia Therapeutics - Pipeline Analysis, Clinical Trials & Results, Patents, Designations

Lewy body dementia is a progressive brain disorder in which Lewy bodies build up in different parts of the brain that regulate cognition, movement and behavior. Lewy bodies are abnormal deposition of a protein called alpha-synuclein. The symptoms associated with the Lewy...

Read More

Ischemia Reperfusion Injury Therapeutics - Pipeline Analysis, Clinical Trials & Results, Patents, Designations, Collaborations

Ischemia reperfusion injury is a medical condition which involves tissue injury, resulting in the interruption of blood supply, and occurs when the blood supply to an area of tissue is cut off. Ischemia-related tissue injury can occur in various organs including heart and...

Read More

Infertility Therapeutics - Pipeline Analysis , Clinical Trials & Results, Patents, Designations

Infertility is defined as the biological inability to conceive or contribute to conception, after having regular unprotected sex. According to the data published by the Department of Health and Human Services, approximately 10% to 15% of couples in the U.S. are infertile...

Read More

Hypoxic-Ischemic Encephalopathy Therapeutics - Pipeline Analysis , Clinical Trials & Results

Hypoxic-ischemic encephalopathy is a serious birth complication that causes obstruction in blood flow in brain during the prenatal, intrapartum or postnatal period. This leads to death of the child or mental disabilities in the first two years of age. Access Detailed Report...

Read More

Hypoxia Therapeutics - Pipeline Analysis , Clinical Trials & Results, Patents

Hypoxia is a condition characterized by inability of the tissues to receive an adequate oxygen supply. This condition is categorized into four types; hypoxic, stagnant, anaemic, fulminating, and histotoxic hypoxia. Hypoxic hypoxia is defined as the lack of oxygen in the arterial...

Read More

Hypoxia-Inducible Factor (HIF) Inhibitor Therapeutics - Pipeline Analysis , Clinical Trials & Results, Patents,

Hypoxia-inducible factor (HIF) inhibitor inhibits the HIF mediated hypoxic responses. HIF is a transcription factor that activate when there is a decrease in the availability of oxygen in the cellular environment. Hypoxia promotes the formation of blood vessels and this homeostatic...

Read More

Hyperphosphatemia Therapeutics - Pipeline Analysis , Clinical Trials & Results

Hyperphosphatemia is a medical condition which involves increased level of serum phosphate concentration in the blood. Phosphate is required for bone and cell formation, genetic coding and energy metabolism. Access More About This Research at: https://www.pharmaproff.com/report/hyperphosphatemia-therapeutics-pipeline-analysis An individual...

Read More

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Therapeutics

Prostate cancer occurs when cells in prostate glands grow uncontrollably. Prostate is an exocrine gland that makes the fluid part of semen and lie below the bladder in front of the rectum. As per the National Institute of Health (NIH), 10.7% of all new cases of cancer in...

Read More

Hormonal Replacement Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations

Hormonal replacement therapy is a type of treatment wherein patients receive a course of hormones in order to get relieve from the menopause related problems. The therapy involves administration of synthetic estrogen and progesterone to overcome decreasing hormone level of...

Read More

Heterozygous Familial Hypercholesterolemia (heFH) Therapeutics - Pipeline Analysis , Clinical Trials & Results

Heterozygous familial hypercholesterolemia (HeFH) is an inherited genetic disorder that affects the body’s ability to control cholesterol. It is characterized by very high LDL (low density lipoprotein) cholesterol (above 190 for adults or above 160 for children) and family...

Read More

Hematopoietic Stem Cell (HSC) Mobilization Therapeutics - Pipeline Analysis , Clinical Trials & Results, Patents, Designations

Mobilization is the recruitment of hematopoietic stem cells (HSC) into peripheral blood from the bone marrow following chemotherapy treatment. There are several advantages for reinfusion of autologous mobilized peripheral blood stem cells over bone marrow HSC. Access More...

Read More

Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics - Pipeline Analysis, Clinical Trials & Results,

Globoid cell leukodystrophy, also known as Krabbe disease, is a genetic disorder which is characterized by decreased production of galactocerebrosidase. The symptoms observed during Krabbe disease are fever, vomiting, loss of head control, irritability and excessive crying,...

Read More

Female Sexual Dysfunction (FSD) Therapeutics - Pipeline Analysis , Clinical Trials & Results, Patents, Designations

Female sexual dysfunction (FSD) prevents the females to experience satisfaction from the sexual activity. FSD can be developed during any phase of the sexual response cycle which consists of excitement, plateau, orgasm and resolution phases. Access More About This Research...

Read More

Female Contraception Therapeutics - Pipeline Analysis , Clinical Trials & Results, Patents, Designations

Female contraception prevents unwanted or unintended pregnancy. When the matured egg cell leave the ovary and ovulation begins, the chances of becoming pregnant increases. The main advantage of using contraceptives is reduction in menstrual bleeding and period pain. Access More...

Read More

Epidermolysis Bullosa (EB) Therapeutics - Pipeline Analysis , Clinical Trials & Results, Patents, Designations

Epidermolysis bullosa (EB), is a rare genetic connective tissue skin disorder that causes blisters and allows skin to become fragile. Blisters and areas of skin loss (erosions) occur in response to minor injury or friction, such as rubbing or scratching. The disease affects...

Read More

Dental Pain Therapeutics - Pipeline Analysis, Clinical Trials & Results

Dental pain, also known as odontogenic pain or tooth pain, arises from the teeth or their supporting structures which includes mucosa, gingivae, maxilla, mandible, or periodontal membrane. Request to Get the Sample Pages at: https://www.pharmaproff.com/request-sample/1129 The...

Read More